PHARMA & FLO
ActiveDeeds, filings and financial milestones
Deadline for the 2026 accounts:
2026
28-08
abbreviated format · 28 days late
2025
28-08
full format · 28 days late
26-02
Gazette deed
Appointment: Thierry DELAHAUT (director)“En assurant la gestion d'une société professionnelle de pharmacie,en ce compris l'acquisition,la location et…” (deed in French) · Legal-form conversion: from private limited company (pre-2019) to private limited company · Thierry DELAHAUT holds 750 shares5 points ▸
Gazette deed
Appointment: Thierry DELAHAUT (director)
“En assurant la gestion d'une société professionnelle de pharmacie,en ce compris l'acquisition,la location et…” (deed in French) · Legal-form conversion: from private limited company (pre-2019) to private limited company · Thierry DELAHAUT holds 750 shares5 points ▸
- 750 shares, mentioned twice in the deed
- Legal-form conversion, from private limited company (pre-2019) to private limited company
- Director appointment, Thierry DELAHAUT
- General meeting, 20-02-2025
- Thierry DELAHAUT holds 750 shares
- The deed holds 6 more points.
2024
31-12
Financial
Highest result from 2018 to 2025net €315,140 ▲11.9%
The operating result of €304,656 and the net result of €315,140 are both a record.
26-08
full format · 26 days late
2023
20-07
full format · 11 days before the deadline
2022
07-07
full format · 24 days before the deadline
2021
31-12
Financial
Equity above €1mequity €1.0m ▲16.3%
With a profit in every financial year since 2018, equity grows to €1.0m.
02-08
full format · 2 days late
2020
30-06
full format · 31 days before the deadline
2019
31-12
Financial
Equity above €500,000equity €761,854 ▲61.6%
With a profit in every financial year since 2018, equity grows to €761,854.
03-07
full format · 28 days before the deadline
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
Sources:Publications in the Belgian Official GazetteFilings with the National Bank